Clinical Trial Update: Use of Probiotics to Reduce Infections, Death and ESBL Colonisation [Phase 3]

View source ↗

Summary

Phase 3 clinical trial completed evaluating the use of probiotics to reduce infections, death, and ESBL colonisation in neonates at risk for neonatal sepsis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neonatal Sepsis

Drugs mentioned

• Probiotic (probiotic)

Snippet

Sponsor: Haydom Lutheran Hospital | Conditions: Neonatal Sepsis | Phase 3 | Status: COMPLETED